Cargando…
Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts et al., 2021)
Autores principales: | Talbert, Jeffery, Bohler, Robert, Frazier, Lisa, El-Bassel, Nabila, Freeman, Patricia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759018/ https://www.ncbi.nlm.nih.gov/pubmed/34298354 http://dx.doi.org/10.1016/j.drugalcdep.2021.108888 |
Ejemplares similares
-
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019) -
Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021) -
Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
por: Evoy, Kirk E, et al.
Publicado: (2021) -
Variations in Schedule III prescription patterns in a Medicaid population pre- and post-policy
por: Nagarajan, Radhakrishnan, et al.
Publicado: (2021) -
Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)